Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Treasury Shares (2022 - 2025)

Kezar Life Sciences (KZR) has disclosed Treasury Shares for 4 consecutive years, with $497.0 as the latest value for Q4 2025.

  • For Q4 2025, Treasury Shares fell 95.45% year-over-year to $497.0; the TTM value through Dec 2025 reached $497.0, down 95.45%, while the annual FY2025 figure was $497.0, 95.45% down from the prior year.
  • Treasury Shares hit $497.0 in Q4 2025 for Kezar Life Sciences, down from $1127.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $483276.0 in Q1 2023 and bottomed at $497.0 in Q4 2025.
  • Average Treasury Shares over 4 years is $163972.4, with a median of $41935.0 recorded in 2022.
  • Year-over-year, Treasury Shares surged 1052.44% in 2023 and then plummeted 96.37% in 2024.
  • Kezar Life Sciences' Treasury Shares stood at $434790.0 in 2022, then plummeted by 94.95% to $21945.0 in 2023, then crashed by 50.26% to $10916.0 in 2024, then tumbled by 95.45% to $497.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $497.0, $1127.0, and $8318.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.